| Vol. 2.41 – 4 November, 2021 |
| |
|
|
| Researchers reported a high-throughput screen based on the functional interaction of mouse- or patient-derived breast tumor organoids and tumor-specific cytotoxic T cells for the identification of epigenetic inhibitors that promoted antigen presentation and potentiated T cell-mediated cytotoxicity. [Nature Biomedical Engineering] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists showed that an ovarian model generated normal offspring and detected drug toxicity. The ovarian organoids produced oocytes and exhibited endocrine functions. [Biomaterials] |
|
|
|
| Investigators presented a high-throughput, scalable, low-cost, on-chip microfluidic potency assay with improved functional predictive power and recapitulation of in vivo secretory responses compared to traditional approaches. [Advanced Healthcare Materials] |
|
|
|
| Researchers aimed to better understand the tumor epithelium-targeted mechanisms of bacterial cancer therapy by using autochthonous mouse models of intestinal cancer and tumor organoid cultures to assess the effectiveness and consequences of oral treatment with aromatase A-deficient Salmonella enterica serovar Typhimurium. [JCI Insight] |
|
|
|
| The effect and mechanism of aurora kinase A (AURKA) on liver regeneration were studied using a 70% hepatectomy model. Human liver organoids were used as an in vitro model to investigate the effect of AURKA on hepatocyte proliferation. [Liver International] |
|
|
|
| The elevated apoptosis of neural stem/progenitors was recapitulated using Cep55-deficient human cerebral organoids and investigators could rescue the phenotype by inhibiting active Gsk3β. [PLoS Genetics] |
|
|
|
| The authors created a 3D model of vascularized spheroid cells using an injection-molded microfluidic chip. Gene expression analysis and immunostaining revealed that the vascular network greatly enhanced spheroid differentiation and reduced apoptosis. [Biotechnology and Bioengineering] |
|
|
|
| Investigators described a pilot prospective observational study with the goal of determining whether esophageal cancer patient-derived organoids created from treatment-naive patients could model or predict clinical outcomes. [Scientific Reports] |
|
|
|
| A new “endocrine pancreas” delivered islet hormones physiologically into the hepatic portal vein. Treatment of insulin-dependent dogs with allogeneic canine neo-islets consistently improved glycemic control without the need for antirejection drugs. [PLoS One] |
|
|
|
|
| Advances in 3D organoid culture technology have led to the development of novel physiological systems that model the tissues of origin more precisely than traditional culture methods. [Cancer Communications] |
|
|
|
|
| Signet Therapeutics and XtalPi Inc. announced the expansion of their AI drug discovery collaboration to include a new first-in-class program against a novel cancer target identified by Signet, combining XtalPi’s AI drug discovery platform with Signet’s unique novel organoid disease models. [XtalPi, Inc. (PR Newswire, Inc.)] |
|
|
|
|
| December 1 – 10, 2021 Virtual |
|
|
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| Roche – Basel, Switzerland |
|
|
|
| The Ecole Polytechnique Fédérale de Lausanne – Lausanne, Switzerland |
|
|
|
| VIB Center for Inflammation Research – Ghent, Belgium |
|
|
|
| Radboud University Medical Center – Nijmegen, The Netherlands |
|
|
|
|